Evidence map›Paper›PMID 40966084›Full record

ArticleCell reports2025

A comprehensive analysis of supermere, exomere, and extracellular vesicle isolation and cargo in colorectal cancer.

Oleg S Tutanov, Clark Massick, Marisol Ramirez, James N Higginbotham, Lizandra Jimenez, Mark Castleberry, Zheng Cao, Eliana John, Maxwell S Hamilton, Qin Zhang and 14 more

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Extracellular vesicles inEXO : beyond the cell · 2026
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Oleg S TutanovDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Clark MassickDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Marisol RamirezDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
James N HigginbothamDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Lizandra JimenezDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Mark CastleberryDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Zheng CaoDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Eliana JohnDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Maxwell S HamiltonProgram in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Qin ZhangDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Dennis K JeppesenDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Danielle L MichellDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA.
Sarah E GlassDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Purvi PatelProteomics Core, Mass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA.
Kristie L RoseDepartment of Biochemistry, Vanderbilt University, Nashville, TN, USA; Proteomics Core, Mass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA.
Evan KrystofiakDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Hua-Chang ChenDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Quanhu ShengDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Qi LiuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
James G PattonCenter for Extracellular Vesicle Research, Vanderbilt University, Nashville, TN, USA; Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA.
Alissa M WeaverDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; Center for Extracellular Vesicle Research, Vanderbilt University, Nashville, TN, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jeffrey L FranklinDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Kasey C VickersDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; Center for Extracellular Vesicle Research, Vanderbilt University, Nashville, TN, USA. Electronic address: kasey.c.vickers@vumc.org.
Robert J CoffeyDepartment of Medicine, Vanderbilt University School of Medicine and Medical Center, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; Center for Extracellular Vesicle Research, Vanderbilt University, Nashville, TN, USA. Electronic address: robert.coffey@vumc.org.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KON, VALENTINA · 2014 to 2025
$24.7M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEPHEN W. FESIK · 2019 to 2026
$19.6M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Roles for Supermeres in CRC ProgressionP01CA229123 · NCI · VANDERBILT UNIVERSITY · PI Alissa M Weaver · 2020 to 2026
$12.9M
Integrated approach to study early and late events in colonic neoplasia: mouse to manR35CA197570 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2017 to 2026
$9.4M
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted TherapyR01CA260958 · NCI · VANDERBILT UNIVERSITY · PI COOK, REBECCA SARA, DUVALL, CRAIG LEWIS · 2021 to 2025
$3.0M
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasmaUH3CA241685 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHAREST, ALAIN, COFFEY, ROBERT J. · 2021 to 2022
$2.1M
Novel functions of plasminogen and its diverse cargo in bloodR01HL173598 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kasey C Vickers · 2024 to 2026
$1.1M
American Heart Association-American Stroke Association 971070NCI NIH HHS P01 CA229123NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA236733NCI NIH HHS R01 CA260958NCI NIH HHS R35 CA197570NCI NIH HHS UH3 CA241685NEI NIH HHS P30 EY008126NHLBI NIH HHS P01 HL116263NHLBI NIH HHS R01 HL173598NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637NIH HHS S10 OD034315
6 · The paper itself

Abstract

Biofluids contain a heterogeneous mixture of extracellular vesicles and non-vesicular nanoparticles (including exomeres and supermeres) that transport a diverse array of proteins, RNA, and lipids. Our previous efforts to characterize the contents of these carriers in colorectal cancer relied on 2D culture systems requiring large-scale setups and time-consuming ultracentrifugation-based isolation. To streamline this process, we have combined 3D hollow-fiber bioreactor production and fast-protein liquid chromatography-based size-exclusion chromatography. Here, we compare the impact of culture methods and purification strategies on small extracellular vesicle, exomere, and supermere cargo. Proteomic analyses show consistently distinct profiles for extracellular vesicles, exomeres, and supermeres regardless of culture conditions or isolation method. In contrast, these two variables influence small RNAs, their base modifications, and lipidomic profiles. We present an online tool to query these and future secretome datasets (https://superomics.shinyapps.io/browse).

Indexed as

Colorectal NeoplasmsExtracellular VesiclesCell Line, TumorHumansProteomicsCP: CancerCP: GenomicsEVexomeresexosomesextracellular RNAextracellular vesiclesFPLChollow fiber bioreactorlipidomicsnon-vesicular extracellular nanoparticlesNVEPproteomicsRNA-seqSECsecreted RNAssEVsupermeres

Identifiers

PMID40966084
PMCPMC12632813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.